Heather Huet, Ph.D.

Heather Huet, Ph.D. is Head of Oncology Strategic Operations, OBU at Takeda. Dr. Huet also serves as Head, Portfolio Strategy and Operations, Oncology R&D at Takeda. She joined the company in 2020 and is focused on portfolio strategy, program execution, managing external alliances and business operations supporting global Oncology R&D.

Prior to joining Takeda, Dr. Huet was Head of Program Leadership and Portfolio Management and a member of the executive team at Unum Therapeutics, a biotechnology company focused on the discovery and clinical development of next-generation engineered cell therapies, where she was responsible for the strategy and execution of clinical-stage-product candidates and managing strategic partnerships.

Prior to joining Unum Therapeutics, Dr. Huet spent 15 years as a lab head at Biogen and Novartis, leading global, cross-functional project teams that progressed novel cell therapy and large-molecule therapeutics from discovery to Phase 1 clinical trials.

Dr. Huet received a BS with Honors from the University of Texas at Austin and a Ph.D. in Virology from Harvard University.